Inventor
STEPAN ANTONIA FRIEDERIKE
US10 patents
Patents
10 patentsUS9695171B2Jul 4, 2017
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors
PFIZER10 citations83
US9642855B2May 9, 2017
Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors
PFIZER6 citations83
US9156845B2Oct 13, 2015
4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors
PFIZER6 citations83
US8916564B2Dec 23, 2014
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
PFIZER6 citations82
US10039753B2Aug 7, 2018
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors
PFIZER14 citations81
US11161844B2Nov 2, 2021
Cyclic substituted imidazo[4,5-c]quinoline derivatives
PFIZER1 citations60
US9751877B2Sep 5, 2017
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
PFIZER1 citations60
US11312713B2Apr 26, 2022
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
PFIZER0 citations59
US9193726B2Nov 24, 2015
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders
PFIZER1 citations50
US9765073B2Sep 19, 2017
Cyclopropabenzofuranyl pyridopyrazinediones
PFIZER1 citations49